Compare Inovio Pharmaceuticals Inc (INO) vs MetLife Inc. Common Stock (MET) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs MetLife Inc. Common Stock — how do they compare? Inovio Pharmaceuticals Inc trades at $1.1 (market cap $119.42M), while MetLife Inc. Common Stock trades at $98.97 (market cap $60.87B). The key difference: MetLife Inc. Common Stock is far larger — about 509.7× Inovio Pharmaceuticals Inc's market cap, and MetLife Inc. Common Stock pays a 2.47% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Inovio Pharmaceuticals Inc for 43 Days and MetLife Inc. Common Stock for 0 Days on average.
| INO | MET | |
|---|---|---|
Market Cap | $119.42M | $60.87B |
Volume | 2,789,649 | 3,175,937 |
Sector | Health | Financials |
52-Week High | $2.65 | $99.95 |
52-Week Low | $0.66 | $67.70 |
Typical Hold Time | 43 Days | 0 Days |
Enterprise Value | $90.75M | $81.79B |
Dividend Yield | — | 2.47% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INO trades at $1.09, down 3.54% on the day, with a bearish technical signal driven by moving averages. The company reported a net loss of $84.95 million in 2025 on minimal revenue of $65,340, with negative profitability metrics, but has beaten EPS estimates in recent quarters. Key near-term catalyst is the FDA's October 30, 2026 PDUFA date for INO-3107.
The investment case hinges on regulatory approval of INO-3107, with a consensus price target of $2.75 implying significant upside. However, extreme financial losses, high cash burn, and dependence on dilutive financing pose substantial risks. Analyst sentiment is cautiously optimistic but reflects high uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About MetLife Inc. Common Stock
MetLife provides insurance, annuities, employee benefits, and asset management services. Its products serve individuals, employers, and institutions.
Read more on MET →
